Search Results
Sep 08, 2026, 10:06 ET Amino Minder Brings Real Pharmacokinetic Modeling to Peptide and GLP-1 Tracking, Now Live on the Web -- Android App Coming Soon
aminominder.com), a peptide, GLP-1, TRT, and HRT protocol tracker built around a feature no competing app currently claims: a real pharmacokinetic (PK) engine that estimates and graphs a user's plasma
More news about: Amino Minder
Sep 08, 2026, 07:30 ET Marzano Resources announces new guide to help educators build a lifelong path to teaching excellence
strengthen instructional expertise through purposeful practice and continuous professional growth.Built around the High Reliability Teacher (HRT) model, the book guides educators through three progressive levels of instructional development, helping them establish effective teaching practices,
More news about: Marzano Resources
Aug 10, 2026, 13:01 ET Cuvo Health, the #1 White Label Telehealth Platform, Surpasses 300 Exclusive Providers Serving All 50 States
wellness centers, and fitness practices nationwide. Operators launch a telehealth business offering GLP-1 weight loss, peptides, TRT, women's HRT, hair loss, ED treatment, concierge medicine, primary care, urgent care, mental health, and dermatology under their own brand, while retaining full ownership
More news about: Cuvo Health
Aug 06, 2026, 07:15 ET Hydreight to Participate in Canaccord Genuity's 46th Annual Growth Conference in Boston
patient support. Through VSDHOne, businesses can offer physician-supervised healthcare programs including GLP-1s, peptides, hormone replacement therapy (HRT), testosterone replacement therapy (TRT), weight management, hair loss, skincare, sexual health, longevity, IV wellness, diagnostics, and other personalized
More news about: Hydreight Technologies Inc.
Aug 04, 2026, 07:30 ET Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand
licensed healthcare providers in one, connected member experience. Eligible members may receive clinical evaluation for hormone replacement therapy (HRT), when medically appropriate, following a comprehensive clinical assessment conducted in accordance with evidence-based clinical guidelines and applicable
More news about: DarioHealth Corp.
Jul 30, 2026, 08:25 ET Health-E Commerce® Expands Beyond E-Commerce with Launch of Patiently™ Telehealth Platform Offering Personalized, FSA/HSA Eligible Weight Loss and Menopause Support
Patiently™ launches with two of today's fastest-growing telehealth categories: GLP-1s for medical weight loss and hormone replacement therapy (HRT) for perimenopause and menopause support. By integrating with FSA Store® and HSA Store®, Patiently™ brings the entire health journey
More news about: Health-E Commerce
Jul 21, 2026, 08:43 ET Menopause Telehealth Leader Winona Launches Line of Supplements Specifically Formulated to Help Women Navigate the Menopause Transition
women at every stage of their hormone journey. Designed to complement hormone replacement therapy or provide support for women who aren't ready for HRT or don't qualify due to medical reasons, the new supplement line delivers science-backed solutions that meet women wherever they are in their health
More news about: Winona
Jul 20, 2026, 08:00 ET Musely Ranked #1 Health & Care Platform in Newsweek's America's Best Online Platforms 2026
make expert prescription care more accessible through technology. Today, Musely offers personalized treatments across dermatology, hair restoration, HRT / menopause, and longevity, helping more than 1.3 million patients receive care from the comfort of home."From the beginning, we've believed that
More news about: Musely
Jul 09, 2026, 17:04 ET Peptide Tracker Launches on Google Play, Bringing Dedicated Protocol Tracking to Android
Peptide Tracker supports protocols for common compounds, including semaglutide, tirzepatide, BPC-157, TB-500, TRT, HRT, and custom stacks. The app is intentionally narrow in scope. It does not sell compounds, issue prescriptions, or provide medical services. Users supply
More news about: Peptide Tracker
Jun 30, 2026, 10:30 ET UFC GYM, NexGen MD Scientific Launch PWR Clinics and Expansion of Longevity Clinic Network
delivers medically supervised longevity services, including peptide therapy, GLP-1 programs, hormone replacement therapy (HRT), testosterone replacement therapy (TRT), IV therapy, and aesthetic treatments including Botox and fillers. This will be done inside trusted fitness
More news about: NexGen MD Scientific; UFC GYM
Jun 23, 2026, 08:25 ET Women Seeking Menopause Care Report an Average of Nine Symptoms at Once, New Analysis of 100,000+ Patient Assessments Finds
and joint discomfort.When appropriate, Winona offers personalized treatment plans that may include hormone replacement therapy, bioidentical HRT, estrogen, progesterone, vaginal estrogen, and non-hormonal options. Winona also provides education and community support for women navigating hormone
More news about: Winona
Jun 16, 2026, 09:00 ET Ivim Health launches HormoneIQ™, treating a woman's hormone symptoms as clinical data
built one of the most thoughtful clinical programs we've seen in hormone optimization, and we're proud that HypoSpray will be part of their women's HRT formulary," said HypoSpray Pharma Chairman Kenneth B. Kirby.Physician-prescribed protocols include estradiol, progesterone, DHEA, GLP-1
More news about: Ivim Health
Jun 02, 2026, 14:43 ET Demand for Compounding Pharmacies in USA to Reach USD 12.79 Billion by 2036 Amid Growing Need for Personalized Therapies and Specialized Medication Solutions
applications.Among therapeutic areas, demand remains particularly strong across:Pain ManagementHormone Replacement Therapy (HRT)DermatologyPediatricsVeterinary MedicineRegionallySouth is projected to
More news about: Future Market Insights
Jun 01, 2026, 09:00 ET Millions of Women Go Through Menopause. Research Hasn't Kept Up.
thinning, and joint pain.When appropriate, Winona offers personalized treatment plans that may include hormone replacement therapy, bioidentical HRT, estrogen, progesterone, vaginal estrogen, and non-hormonal options. Winona also provides education and community support for women navigating hormone
More news about: Winona
May 19, 2026, 09:00 ET Study Validates Glycans as Aging Biomarker and Finds Therapeutic Plasma Exchange Yields Greatest Reduction
measurable reductions in glycan patterns during structured longitudinal evaluation: therapeutic plasma exchange (TPE), hormone replacement therapy (HRT), and caloric restriction. Among these, TPE produced the largest per-month effect, and the authors note that this is among the first demonstrations of
More news about: Circulate Health
May 19, 2026, 09:00 ET Study Validates Glycans as Aging Biomarker and Finds Therapeutic Plasma Exchange Yields Greatest Reduction
measurable reductions in glycan patterns during structured longitudinal evaluation: therapeutic plasma exchange (TPE), hormone replacement therapy (HRT), and caloric restriction. Among these, TPE produced the largest per-month effect, and the authors note that this is among the first demonstrations of
More news about: Circulate Health
May 13, 2026, 12:29 ET Wall Street Veteran Iggy Ioppe Joins Theo as Chief Investment Officer
Management and Standard Chartered. Theo raised a $20M Series A led by Hack VC and Anthos Capital, with participation from investors at Citadel, Jane Street, HRT, Optiver, IMC, Five Rings, and JPMorgan.Learn more at theo.xyz.
More news about: Theo Network
May 08, 2026, 09:30 ET Enhanced Group CEO, Maximilian Martin, Issues Letter to Shareholders
includes two top tier OTC supplement stacks focused on longevity and strength & recovery. On the telehealth side, our offering currently spans across HRT, TRT, prescription longevity drugs and peptides. We're expanding from a static product offering to fully personalized performance and longevity protocols
More news about: Enhanced
Apr 21, 2026, 08:50 ET ProRx Pharma Continues to Grow Operational Footprint, Triples Production Capacity to Support Demand for Compounded Medications
capacity. In addition, the company is adding a sterile hazardous drug clean room to support the production of an expanded Hormone Replacement Therapy (HRT) portfolio. The company has also invested in voluntary training through the
More news about: ProRx Pharma
Apr 17, 2026, 09:09 ET Theo's Gold-Backed Stablecoin Held Steady Through Global Disruption, Now Targets $1B in Deposits
in assets. Theo's $20 million funding round was led by Hack VC and Anthos Capital, with participation from angel investors at Citadel, Jane Street, HRT, Optiver, IMC, Five Rings, and JPMorgan.thUSD is accessible via http://app.theo.xyzAbout
More news about: Theo
Apr 09, 2026, 17:43 ET /C O R R E C T I O N -- Sequel Brands/
biomarker analysis, testing, and metabolic profiling, with personalized protocols incorporating solutions as they emerge – such as NAD, GLP-1, HRT, peptides, supplements, and IV therapies. Designed for both novices and wellness enthusiasts, these solutions will provide personalized insights and
More news about: Sequel Brands
Apr 08, 2026, 13:07 ET New Physician-led Nonprofit Formed To Advance Safety, Science, and Standards in Hormone Therapy, To Develop First Comprehensive Clinical Guidelines
Society of Proactive Medicine, led by a multi-disciplinary coalition of leading healthcare professionals, has been formed to ensure hormone therapy (HRT) including bio-identical hormone replacement therapy (BHRT) including testosterone replacement therapy (TRT) is used safely, effectively, and according
More news about: Society of Proactive Medicine
Apr 01, 2026, 12:52 ET 'America's Best in Medicine' Honoree Amy Dunn Launches Wildwood Pelvic Health, Filling a Vital Gap in Idaho's Healthcare Crisis
specialized treatments designed to support women's wellness at every stage of life.Hormone Optimization: Specialized Hormone Replacement Therapy (HRT) for women and Testosterone Replacement Therapy (TRT) for men to restore balance, energy, and long-term wellness.Sexual Health & Performance:
More news about: Wildwood Pelvic Health
Mar 03, 2026, 11:16 ET New Research from The Fuchsia Tent Shows Making Midlife Women Visible in Employer Health Data Could Save U.S. Companies $26.6B
they are designed to help. The Formulary Wall: treatment pathways are blocked by undertrained providers and formulary barriers that have driven HRT utilization from 26.9% down to 4.7% over two decades. Only 6.8% of medical residents are trained in menopause care, and 75% of women who seek help do
More news about: The Fuchsia Tent
Mar 02, 2026, 01:01 ET New study finds early hormone replacement therapy reduces risk of osteoporosis and fractures for older women
the non-HRT group demonstrated a significantly higher risk of developing osteoporosis compared to the HRT group (OR 1.18, 95% CI 1.092– 1.284, p < 0.0001).For fractures, no significant difference was found between the groups at 3 years (RR 1.02, not significant), but the non-HRT group had
More news about: American Academy of Orthopaedic Surgeons